Clinical Trial Update: Acetaminophen to Prevent Ischemic Oxidative Reperfusion Injury During Percutaneous Coronary Intervention for Acute Myocardial Infarction [NA]

View source ↗

Summary

A clinical trial evaluating acetaminophen to prevent ischemic oxidative reperfusion injury during PCI for acute myocardial infarction was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Acetaminophen (Acetaminophen)

Snippet

Sponsor: Vanderbilt University | Conditions: Acute Myocardial Infarction | NA | Status: WITHDRAWN